---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-095029"
form_type: "8-K"
ticker: "TCRT"
cik: "0001107421"
company_name: "Alaunos Therapeutics, Inc."
filed_at: "2025-07-10T23:59:59+00:00"
generated_at: "2026-05-18T07:08:11.949373+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Alaunos shareholders approve 10x increase in authorized common shares, reverse split authorization

## Summary
- Stockholders approved increasing authorized common shares from 5M to 50M; amendment effective July 10, 2025.
- Authorized reverse stock split at ratio between 1:5 and 1:20, at Board's discretion.
- Stockholders approved raising shares available under 2020 Equity Incentive Plan from 130,745 to 1,130,745.
- Elected directors: Robert W. Postma, Jaime Vieser, Holger Weis; Dale Hogue resigned before meeting and was not reelected.

## SEC filing metadata
- accession: 0000950170-25-095029
- form_type: 8-K
- ticker: TCRT
- cik: 0001107421
- company_name: Alaunos Therapeutics, Inc.
- filed_at: 2025-07-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1107421/000095017025095029/0000950170-25-095029-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1107421/000095017025095029/tcrt-20250703.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-095029
- JSON: https://secwatch.observer/filing/0000950170-25-095029.json
- Plain text: https://secwatch.observer/filing/0000950170-25-095029.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.